D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia

@article{Buchsbaum2006D2D3DR,
  title={D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia},
  author={Monte S. Buchsbaum and Bradley T. Christian and Douglas S. Lehrer and Tanjore K. Narayanan and Bingzhi Shi and Joseph C. Mantil and Eileen M. Kemether and Terrence R. Oakes and Jogeshwar Mukherjee},
  journal={Schizophrenia Research},
  year={2006},
  volume={85},
  pages={232-244}
}
BACKGROUND Abnormalities in the dopaminergic system are implicated in schizophrenia. [F-18]fallypride is a highly selective, high affinity PET ligand well suited for measuring D2/D3 receptor availability in the extrastriatal regions of the brain including thalamus, prefrontal, cingulate, and temporal cortex, brain regions implicated in schizophrenia with other imaging modalities. METHODS Resting [F-18]fallypride PET studies were acquired together with anatomical MRI for accurate… Expand
D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia
TLDR
The results of this study demonstrate that lower fallypride binding potential in patients with schizophrenia may be associated with better performance, and are consistent with previous studies that failed to find cognitive improvements with typical dopamine-blocking medications. Expand
Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET
TLDR
Patients with schizophrenia showed higher dopamine synthesis in the left caudate nucleus, and dopaminergic transmission in the thalamus and right temporal cortex might be implicated in the expression of symptoms in schizophrenia. Expand
18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls
TLDR
The regions with decreased BP(ND) tend to match brain regions previously reported to show alterations in metabolic activity and blood flow and areas associated with the symptoms of schizophrenia. Expand
Cerebral morphology and dopamine D2/D3 receptor distribution in humans: A combined [18F]fallypride and voxel-based morphometry study
TLDR
Cerebral morphology, particularly grey matter density, correlates with [(18)F]fallypride BP(ND) in a regionally specific manner, and clinical studies comparing dopamine receptor availability between clinical and control groups may benefit by accounting for potential differences in cerebral morphology that exist even after spatial normalization. Expand
Relationship of frontal D(2/3) binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients.
TLDR
The results suggest that cortical D(2/3) receptor function may be more involved in some cognitive functions in patients with schizophrenia than in healthy people, suggesting that information processing in schizophrenia may be characterized by lower signal:noise ratios. Expand
Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects
TLDR
DA D(2)r-mediated neurotransmission in the substantia nigra consistent with nigral dysfunction in schizophrenia is demonstrated and it is suggested that both temporal cortical and ventral striatal DA D( 2)r mediate positive symptoms. Expand
Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter.
TLDR
Altered DAT in the thalamus might be related to the pathophysiology and clinical symptoms of schizophrenia. Expand
The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging
TLDR
These data represent the first report of large cohort in vivo D2/D3 dopamine whole brain binding in the adolescent brain and will serve as a valuable comparison for understanding dopamine changes during this critical time of development and provide a framework for creating a dopaminergic biochemical atlas for the rhesus monkey. Expand
Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability.
TLDR
It is speculated that high baseline D(2/3)-receptor availability may impart benefits with regard to cognitive flexibility, but increases the risk of maladaptive information processing in the face of environmental stresses and challenges. Expand
The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride
TLDR
A significant association between excitement symptom severity and D2/3 receptor availability in the insula in schizophrenia is revealed, suggesting a possible important role of D2-3 receptor-mediated neurotransmission in the Insula and related limbic system in the pathophysiology of this specific symptom cluster. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
TLDR
The lower BP values indicate fewer D2 receptors in the anterior cingulate cortex in patients with schizophrenia, suggesting alterations in D2 receptor function in the extrastriatal region may underlie the positive symptoms of schizophrenia. Expand
Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
TLDR
The preliminary finding of low thalamic D2/D3 BP in patients strengthens the hypothesis that the thalamus is a key region in the pathophysiology of schizophrenia and provides additional support to the view that the age effect on D2-D3 receptors differ between brain regions. Expand
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
TLDR
The subregions with low D(2) receptor binding comprise primarily the dorsomedial nucleus and pulvinar, two important components in circuitries previously suggested in the pathophysiology of schizophrenia. Expand
Extrastriatal dopamine D2/3 receptor density and distribution in drug-naive schizophrenic patients
TLDR
The findings indicated an extremely low D2/3 receptor binding among patients in temporal cortex in both hemispheres when compared with controls, which support the previous hypothesis on dysfunction of mesocortical DA function behind the cognitive and negative symptoms in schizophrenia. Expand
Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain
  • H. Olsson, C. Halldin, C. Swahn, L. Farde
  • Chemistry, Medicine
  • Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 1999
TLDR
The short time of a PET measurement using [11C]FLB 457 seemed not to be sufficient for reliable determination of the high binding potential in the striatum, and the potential for PET quantification of minute receptor populations in the human brain is shown. Expand
Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia
TLDR
The results suggest that a systems-level change reflected in the connectivity of D2 receptor binding is present in schizophrenia. Expand
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
TLDR
The hypothesis of generally elevated central D2 dopamine receptor densities in schizophrenia was not supported by the present findings, and significantly higher densities were found in the left than in the right putamen but not in the caudate nucleus. Expand
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
TLDR
Schizophrenia itself is associated with an increase in brain D2 dopamine receptor density, and the densities in the caudate nucleus were higher in both groups of patients than in the normal volunteers. Expand
Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone
Abstract Positron emission tomography (PET) with 11 C- N -methylspiperone as the radioligand was carried out in 25 chronic schizophrenic patients to determine dopamine D 2 receptor density estimatesExpand
Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
TLDR
Postmortem analysis of the monkey brain revealed significant 18F-fallypride binding in the striata, whereas binding was also observed in extrastriatal regions such as the thalamus, cortical areas, and brain stem. Expand
...
1
2
3
4
5
...